Copyright Reports & Markets. All rights reserved.

Global Naloxone Hydrochloride Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Naloxone Hydrochloride Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Naloxone Hydrochloride Market Size Growth Rate by Product
      • 1.4.2 ≥ 98%
      • 1.4.3 ＜ 98%
    • 1.5 Market by End User
      • 1.5.1 Global Naloxone Hydrochloride Market Size Growth Rate by End User
      • 1.5.2 Injection
      • 1.5.3 Tablet
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Naloxone Hydrochloride Market Size
      • 2.1.1 Global Naloxone Hydrochloride Revenue 2014-2025
      • 2.1.2 Global Naloxone Hydrochloride Sales 2014-2025
    • 2.2 Naloxone Hydrochloride Growth Rate by Regions
      • 2.2.1 Global Naloxone Hydrochloride Sales by Regions
      • 2.2.2 Global Naloxone Hydrochloride Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Naloxone Hydrochloride Sales by Manufacturers
      • 3.1.1 Naloxone Hydrochloride Sales by Manufacturers
      • 3.1.2 Naloxone Hydrochloride Sales Market Share by Manufacturers
      • 3.1.3 Global Naloxone Hydrochloride Market Concentration Ratio (CR5 and HHI)
    • 3.2 Naloxone Hydrochloride Revenue by Manufacturers
      • 3.2.1 Naloxone Hydrochloride Revenue by Manufacturers (2014-2019)
      • 3.2.2 Naloxone Hydrochloride Revenue Share by Manufacturers (2014-2019)
    • 3.3 Naloxone Hydrochloride Price by Manufacturers
    • 3.4 Naloxone Hydrochloride Manufacturing Base Distribution, Product Types
      • 3.4.1 Naloxone Hydrochloride Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Naloxone Hydrochloride Product Type
      • 3.4.3 Date of International Manufacturers Enter into Naloxone Hydrochloride Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Naloxone Hydrochloride Sales by Product
    • 4.2 Global Naloxone Hydrochloride Revenue by Product
    • 4.3 Naloxone Hydrochloride Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Naloxone Hydrochloride Breakdown Data by End User

    6 North America

    • 6.1 North America Naloxone Hydrochloride by Countries
      • 6.1.1 North America Naloxone Hydrochloride Sales by Countries
      • 6.1.2 North America Naloxone Hydrochloride Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Naloxone Hydrochloride by Product
    • 6.3 North America Naloxone Hydrochloride by End User

    7 Europe

    • 7.1 Europe Naloxone Hydrochloride by Countries
      • 7.1.1 Europe Naloxone Hydrochloride Sales by Countries
      • 7.1.2 Europe Naloxone Hydrochloride Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Naloxone Hydrochloride by Product
    • 7.3 Europe Naloxone Hydrochloride by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Naloxone Hydrochloride by Countries
      • 8.1.1 Asia Pacific Naloxone Hydrochloride Sales by Countries
      • 8.1.2 Asia Pacific Naloxone Hydrochloride Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Naloxone Hydrochloride by Product
    • 8.3 Asia Pacific Naloxone Hydrochloride by End User

    9 Central & South America

    • 9.1 Central & South America Naloxone Hydrochloride by Countries
      • 9.1.1 Central & South America Naloxone Hydrochloride Sales by Countries
      • 9.1.2 Central & South America Naloxone Hydrochloride Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Naloxone Hydrochloride by Product
    • 9.3 Central & South America Naloxone Hydrochloride by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Naloxone Hydrochloride by Countries
      • 10.1.1 Middle East and Africa Naloxone Hydrochloride Sales by Countries
      • 10.1.2 Middle East and Africa Naloxone Hydrochloride Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Naloxone Hydrochloride by Product
    • 10.3 Middle East and Africa Naloxone Hydrochloride by End User

    11 Company Profiles

    • 11.1 Sun Pharmaceutical
      • 11.1.1 Sun Pharmaceutical Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Sun Pharmaceutical Naloxone Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Sun Pharmaceutical Naloxone Hydrochloride Products Offered
      • 11.1.5 Sun Pharmaceutical Recent Development
    • 11.2 Siegfried
      • 11.2.1 Siegfried Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Siegfried Naloxone Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Siegfried Naloxone Hydrochloride Products Offered
      • 11.2.5 Siegfried Recent Development
    • 11.3 VAV Life Sciences
      • 11.3.1 VAV Life Sciences Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 VAV Life Sciences Naloxone Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 VAV Life Sciences Naloxone Hydrochloride Products Offered
      • 11.3.5 VAV Life Sciences Recent Development
    • 11.4 Xinhua Pharm
      • 11.4.1 Xinhua Pharm Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Xinhua Pharm Naloxone Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Xinhua Pharm Naloxone Hydrochloride Products Offered
      • 11.4.5 Xinhua Pharm Recent Development
    • 11.5 YaoPharma
      • 11.5.1 YaoPharma Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 YaoPharma Naloxone Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 YaoPharma Naloxone Hydrochloride Products Offered
      • 11.5.5 YaoPharma Recent Development
    • 11.6 Gaobo Jingband Pharmaceutical
      • 11.6.1 Gaobo Jingband Pharmaceutical Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Gaobo Jingband Pharmaceutical Naloxone Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Gaobo Jingband Pharmaceutical Naloxone Hydrochloride Products Offered
      • 11.6.5 Gaobo Jingband Pharmaceutical Recent Development
    • 11.7 PUAN Pharmaceutical
      • 11.7.1 PUAN Pharmaceutical Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 PUAN Pharmaceutical Naloxone Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 PUAN Pharmaceutical Naloxone Hydrochloride Products Offered
      • 11.7.5 PUAN Pharmaceutical Recent Development
    • 11.8 Aoxing Group Pharmaceutical
      • 11.8.1 Aoxing Group Pharmaceutical Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Aoxing Group Pharmaceutical Naloxone Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Aoxing Group Pharmaceutical Naloxone Hydrochloride Products Offered
      • 11.8.5 Aoxing Group Pharmaceutical Recent Development
    • 11.9 Easton Biopharmaceuticals
      • 11.9.1 Easton Biopharmaceuticals Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Easton Biopharmaceuticals Naloxone Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Easton Biopharmaceuticals Naloxone Hydrochloride Products Offered
      • 11.9.5 Easton Biopharmaceuticals Recent Development
    • 11.10 Nhwa Pharmaceutical
      • 11.10.1 Nhwa Pharmaceutical Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Nhwa Pharmaceutical Naloxone Hydrochloride Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Nhwa Pharmaceutical Naloxone Hydrochloride Products Offered
      • 11.10.5 Nhwa Pharmaceutical Recent Development

    12 Future Forecast

    • 12.1 Naloxone Hydrochloride Market Forecast by Regions
      • 12.1.1 Global Naloxone Hydrochloride Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Naloxone Hydrochloride Revenue Forecast by Regions 2019-2025
    • 12.2 Naloxone Hydrochloride Market Forecast by Product
      • 12.2.1 Global Naloxone Hydrochloride Sales Forecast by Product 2019-2025
      • 12.2.2 Global Naloxone Hydrochloride Revenue Forecast by Product 2019-2025
    • 12.3 Naloxone Hydrochloride Market Forecast by End User
    • 12.4 North America Naloxone Hydrochloride Forecast
    • 12.5 Europe Naloxone Hydrochloride Forecast
    • 12.6 Asia Pacific Naloxone Hydrochloride Forecast
    • 12.7 Central & South America Naloxone Hydrochloride Forecast
    • 12.8 Middle East and Africa Naloxone Hydrochloride Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Naloxone Hydrochloride Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Naloxone Hydrochloride is the hydrochloride salt of naloxone, a thebaine derivate with opioid antagonist activity.
      The global Naloxone Hydrochloride market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Naloxone Hydrochloride market based on company, product type, end user and key regions.

      This report studies the global market size of Naloxone Hydrochloride in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Naloxone Hydrochloride in these regions.
      This research report categorizes the global Naloxone Hydrochloride market by top players/brands, region, type and end user. This report also studies the global Naloxone Hydrochloride market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Sun Pharmaceutical
      Siegfried
      VAV Life Sciences
      Xinhua Pharm
      YaoPharma
      Gaobo Jingband Pharmaceutical
      PUAN Pharmaceutical
      Aoxing Group Pharmaceutical
      Easton Biopharmaceuticals
      Nhwa Pharmaceutical

      Market size by Product
      ≥ 98%
      ＜ 98%
      Market size by End User
      Injection
      Tablet
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Naloxone Hydrochloride market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Naloxone Hydrochloride market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Naloxone Hydrochloride companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Naloxone Hydrochloride submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Naloxone Hydrochloride are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Naloxone Hydrochloride market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now